The human efficacy record is mixed: the fragment cleared safety trials but missed its primary weight endpoint in its largest study, and development for obesity stopped in 2007
Additionally, they were provided with unrestricted access to food and water to ensure their wellbeing
Weight loss patients who have plateaued on diet and exercise Athletes and active adults seeking faster recovery and reduced inflammation Adults 35+ experiencing declining energy, reduced recovery, or body composition changes associated with aging Biohackers and longevity-focused patients wanting objective optimization protocols Post-surgical patients using BPC-157 to accelerate healing What to Expect at Your First Appointment Free consultation 20-minute call or in-person visit to review goals and health history
There was no phenomenon of brain-type patients stopping the drug due to worsening neurological symptoms in the early stage of penicillamine treatment
BPC-157 is not an alternative to testosterone, growth hormone, or anabolic agents
Theoretical protection against AMD and other age-related eye diseases through cellular maintenance